The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical activity and safety profile of TGR-1202, a novel once daily PI3Kδ inhibitor, in patients with CLL and B-cell lymphoma.
 
Howard A. Burris
No Relationships to Disclose
 
Manish R. Patel
Honoraria - TG Therapeutics
Speakers' Bureau - TG Therapeutics
 
Timothy S. Fenske
No Relationships to Disclose
 
Owen A. O'Connor
Honoraria - Millennium; Mundipharma; Novartis; Seagen
Consulting or Advisory Role - Allos Therapeutics; Millennium; Mundipharma; Novartis; Seagen; Spectrum Pharmaceuticals
Research Funding - Acetylon Pharmaceuticals; Celgene; Millennium; Roche; Seagen; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Acetylon Pharmaceuticals; Millennium; Mundipharma; Seagen; Spectrum Pharmaceuticals
 
Changchun Deng
No Relationships to Disclose
 
Danielle M. Brander
No Relationships to Disclose
 
Martin Gutierrez
Research Funding - Abbvie (Inst); Acceleron Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Esanex (Inst); Gilead Sciences (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); MedImmune (Inst); Novartis (Inst); Rexahn Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Suzanne Fields Jones
No Relationships to Disclose
 
John G. Kuhn
Consulting or Advisory Role - Alza; TG Therapeutics
Speakers' Bureau - Amgen
 
Hari P. Miskin
Employment - TG Therapeutics
Leadership - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
Patents, Royalties, Other Intellectual Property - TG Therapeutics (Inst)
 
Peter Sportelli
Employment - TG Therapeutics
Leadership - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
Patents, Royalties, Other Intellectual Property - TG Therapeutics (Inst)
 
Swaroop V.S. Vakkalanka
Employment - Rhizen Pharmaceuticals
Leadership - Rhizen Pharmaceuticals
Stock and Other Ownership Interests - Rhizen Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Rhizen Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Ian Flinn
Honoraria - TG Therapeutics